Allocations
Buyout specialist Kester Capital (Kester), has invested in Rephine, a provider of Good Manufacturing/Clinical Practice (GMP/GCP) audits and regulatory consulting services to the pharmaceutical industry.
The investment represents Kester’s fourth investment in the Life Sciences sector, and the fourth investment out of its latest fund, Kester Capital II, which closed at its hard cap in August 2020. It also comes at a time of significant positive momentum for Kester, which recently exited Frontier Medical (netting a 3.4x return for its investors), completed two bolt-on acquisitions, and made two hires into its investment team.
Headquartered in Stevenage, and with offices
Global Healthcare Exchange (GHX) has acquired Chicago-based Explorer Surgical Corp, operator of a comprehensive digital and remote case support platform that connects suppliers with healthcare provider teams.
By combining Explorer Surgical’s digital expertise in creating innovative procedure playbooks, tele-mentoring and performance tracking tools with GHX’s cloud-based supply chain network and industry-leading collection of data and clinical evidence, the combined organisation will help providers and suppliers deliver a higher quality standard for patient care. Explorer Surgical will operate as a wholly owned subsidiary of GHX.
“To succeed in value-based healthcare, organisations must democratise knowledge and data to create more efficient
Colorcon, a specialist in pharmaceutical film coatings and specialty excipients, has acquired a majority share in Ideal Cures, a manufacturer of excipients and ready-to-use coating systems for solid oral dosage forms located in India.
The acquisition of Ideal Cures underscores the importance of India in the pharmaceutical sector by providing an expanded service network of manufacturing and technical capabilities, especially for the remotely located economic zones in North India.
Ideal Cures will operate as a fully independent entity within Colorcon. Their business complements Colorcon’s position in the Indian pharmaceutical market with a strong presence in the domestic generic
Citizens M&A Advisory has served as the exclusive financial advisor to Eclipse Advantage, a provider of outsourced supply chain workforce solutions, on its acquisition by Two Sigma Impact.
Eclipse provides a comprehensive suite of labour services for warehouses and distribution centres that increase supply chain productivity and efficiency. Eclipse was a portfolio company of Longshore Capital Partners, a Chicago-based lower middle-market private equity firm. Two Sigma Impact is the impact investing business of Two Sigma.
Pete Westermann, chief executive officer of Eclipse, says: “The Citizens M&A Advisory team was terrific to work with. Citizens assisted us in articulating our complex
Arctos Sports Partners (Arctos), a private investment platform dedicated to providing growth capital and liquidity solutions to professional sports franchise owners in major North American leagues and European soccer, has raised more than USD2.1 billion for its first flagship fund.
The fund complex, Arctos Sports Partners Fund I, along with co-investors and parallel affiliated vehicles, closed with more than USD3.0 billion in Regulatory Assets Under Management from a large, diverse group of global institutional investors. Arctos, which launched in April 2020, has already closed 14 investments into the fund, including ownership stakes in Fenway Sports Group, the Golden State Warriors
Abalos Therapeutics has completed its Series A funding round bringing the total raised in this round to EUR43 million (USD50 million).
The extension was led by Seventure Partners with support from Coparion, Ventura BioMed Investors and Hx Bio Ventures as well as contributions from existing investors from the initial Series A round including Boehringer Ingelheim Venture Fund (BIVF), Gründerfonds Ruhr, NRW.BANK and High-Tech Gründerfonds (HTGF).
The financing underscores the potential of Abalos’ differentiated immuno-virotherapy approach to generate a maximal immune response specifically targeted against a patient’s cancer and its metastases. The proceeds will enable the company to advance its first
Groove, the sales engagement platform for enterprises using Salesforce, has raised a USD45 million Series B round of funding, led by Viking Global Investors.
Existing investors Capital One Ventures, Level Equity, Quest Venture Partners, and Uncork Capital also participated in the round. Groove plans to use the funding to expand its international operations and accelerate its momentum in the enterprise segment of the market, having grown enterprise ARR 114 per cent in the past twelve months with new customers that include Activision, iHeartMedia, LexisNexis, New Relic, TIBCO, Veeva, and Wintrust.
The global shift to digital selling as a result of
LevelTen Energy, a provider of renewable transaction infrastructure, has joined Intercontinental Exchange (ICE), a global provider of data, technology, and market infrastructure in a second close of LevelTen’s Series C funding.
This August, LevelTen announced its first Series C close led by NGP ETP, with participation from leading global technology, energy, and venture capital firms. LevelTen raised USD35 million in this latest round, bringing the company’s aggregate funding to USD62.3 million.
The LevelTen Platform connects the world’s largest group of utility-scale renewable energy buyers, sellers, advisors, and financiers, and delivers the marketplaces, analytics and software these entities need to
C3 (Creating Culinary Communities), global food tech platform founded by Sam Nazarian, announces a USD10 million strategic investment from Lurra Capital AG.
Based in Switzerland, Lurra Capital is an invitation-only private capital investment firm overseeing USD5 billion from UHNW investors and leading family offices. Lurra Capital has a track record of sourcing the most desirable and strategic investment opportunities globally via a highly effective and powerful network with a particular focus on venture capital and real estate. The investment was led by founder and CEO Tyron Birkmeir and is also a strategic partnership that gives C3access to Lurra Capital’s highly
Actis, a global investor in sustainable infrastructure, has completed fundraising for Actis Energy 5 (AE5), significantly exceeding its USD4 billion target. With over USD4.7 billion of fund commitments and significant co-investment, the Energy team expects to deploy around USD6 billion of investable capital in this vintage. The fund will allocate capital globally, providing access to power in markets comprising over 80 per cent of the world’s population.
The AE5 fundraise saw sizeable LP re-ups as well as new commitments from a high quality, diversified investor base. The LP base includes pension funds, insurance companies, endowments, sovereign wealth funds and other
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
